Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 in Grass Pollen Induced Allergic Rhinitis
NCT01448902Phase 2Completed
- Sponsor
- Oxagen
- Start
- Mar 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in allergic rhinitis (AR), sponsored by Oxagen. Started Mar 2007; status: completed.
02
Drugs
timapiprant
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01448902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448902.